Erectile dysfunction (ED) affects millions of men worldwide, leading many to seek convenient and discreet treatment options. Hims, an online telehealth platform, offers consultations and ...

Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...

Bearish flow noted in Hims and Hers Health with 25,948 puts trading, or 1.4x expected. Most active are Mar-25 27 puts and Jan-25 26 puts, with total volume in those strikes near 12,400 contracts.

Hims & Hers has achieved considerable growth in the past few years. As GLP-1 shortages end, however, that could stall a key growth opportunity for the business. Rising competition from Amazon may ...

View Hims & Hers Health, Inc. (HIMS) current and estimated P/E ratio data provided by Seeking Alpha.

Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the stock. But the business is about much more than just one product, and ...

Hot telehealth stock Hims & Hers Health (NYSE: HIMS) has been a roller coaster in 2024. After a recent decline, the stock is down more than 25% from its high. Yet Hims & Hers is still up nearly ...

Online prescription providers are raking in big bucks by preying on fears of hair loss and ED. Paul got his first bottle of pills from Hims in May. He said he didn't really need the generic Viagra ...

It might be of some concern to shareholders to see the Hims & Hers Health, Inc. (NYSE:HIMS) share price down 16% in the last month. But over the last three years the stock has shone bright like a ...